Physician profile
Sydney S Anderson
NPI 1720635642
$878.44
in general payments reported to CMS, 2019-2025
16 companies · $336 in 2025
The $336 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $90.81 · 2022: $73.07 · 2023: $172 · 2024: $206 · 2025: $336.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $715.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $714.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $224.95 | 2023-2025 | Camzyos, Eliquis |
| Novartis Pharmaceuticals Corporation | $114.72 | 2021-2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $71.67 | 2021-2025 | Lifevest |
| Astrazeneca Pharmaceuticals Lp | $63.52 | 2021-2022 | |
| Impulse Dynamics (USA) INC. | $63.47 | 2023-2025 | Optimizer, Optimizer |
| Boston Scientific Corporation | $52.63 | 2022-2025 | Watchman Access System |
| Bayer Healthcare Pharmaceuticals INC. | $44.74 | 2024-2025 | |
| Abbott Laboratories | $38.42 | 2023 | Cardiomems |
| Abiomed | $34.96 | 2024 | Impella |
| Janssen Pharmaceuticals, INC | $33.72 | 2024 | Xarelto |
| Amgen INC. | $32.75 | 2022-2024 | Repatha |
| Itamar Medical INC | $28.63 | 2025 | Watchpatone |
| Lantheus Medical Imaging, INC. | $21.20 | 2021 | |
| Novo Nordisk INC | $19.62 | 2025 | Wegovy |
| Scpharmaceuticals INC. | $19.13 | 2025 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $14.31 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sydney Anderson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.